Norwood Financial’s Quest Diagnostics DGX Stock Holding History

Norwood Financial’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$51.2K	Hold	385	–	–	0.07%	155
2023 Q4	$53.1K	Sell	385 -50	-11%	-$6.57K	0.08%	148
2023 Q3	$53K	Hold	435	–	–	0.09%	143
2023 Q2	$61.1K	Hold	435	–	–	0.09%	138
2023 Q1	$61.5K	Hold	435	–	–	0.1%	129
2022 Q4	$68.1K	Hold	435	–	–	0.11%	117
2022 Q3	$53K	Hold	435	–	–	0.09%	124
2022 Q2	$58K	Hold	435	–	–	0.1%	118
2022 Q1	$60K	Buy	435 +160	+58%	+$22.3K	0.09%	126
2021 Q4	$48K	Buy	+275	New	+$41.8K	0.07%	145

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norwood Financial's DGX Position: Q1 2024 in Review

Norwood Financial held its Quest Diagnostics (DGX) position steady in Q1 2024 at 385 shares worth $51.2K. The position accounts for 0.07% of the portfolio, ranked #155.

Norwood Financial first reported a position in DGX in Q4 2021 and has held it in 10 quarters since. The position peaked at $68.1K in Q4 2022. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

Norwood Financial held 385 shares of Quest Diagnostics worth $51.2K as of Q1 2024.
Norwood Financial left its Quest Diagnostics share count unchanged in Q1 2024.
Quest Diagnostics made up 0.07% of Norwood Financial's portfolio in Q1 2024, its #155 holding.
Norwood Financial first reported a position in Quest Diagnostics in Q4 2021 and has held it in 10 quarters since.
Norwood Financial's Quest Diagnostics position peaked at $68.1K in Q4 2022.
819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.